Marcus, Ulrich
Michel, Janine
Lunchenkov, Nikolay
Beslic, Denis
Treindl, Fridolin
Surtees, Rebecca
Weber, Christoph
Baumgarten, Axel
Nitsche, Andreas
Stern, Daniel
Funding for this research was provided by:
Robert Koch-Institut
Article History
Received: 7 August 2024
Accepted: 7 October 2024
First Online: 14 October 2024
Declarations
:
: The Ethics Committee of the Berlin Medical Association approved the seroprevalence study on 14 February 2023 (Eth-40/22), based on accordance with the principles laid down in the declaration of the World Medical Association as adopted at the 64th General Assembly in Fortaleza in 2013. All study participants gave informed consent.
: Not applicable.
: The authors declare no competing interests.